ng-nitroarginine methyl ester has been researched along with Heart Failure in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (22.06) | 18.2507 |
| 2000's | 27 (39.71) | 29.6817 |
| 2010's | 16 (23.53) | 24.3611 |
| 2020's | 10 (14.71) | 2.80 |
| Authors | Studies |
|---|---|
| Booz, C; Buchner, K; Eichler, K; Frey, N; Gruber-Rouh, T; Gruenewald, LD; Hagenmueller, M; Hardt, SE; Koch, V; Martin, S; März, W; Riffel, JH; Vogl, TJ; Yel, I | 1 |
| Catalina, CO; Francisco, DC; Lauro, FV; Magdalena, AR; Marcela, RN; Maria, LR; Montserrat, MG; Virginia, MM | 1 |
| Belacel-Ouari, M; Domenichini, S; Domergue, V; Fischmeister, R; Hubert, F; Idres, S; Leblais, V; Lefebvre, F; Manoury, B; Mika, D; Wang, L | 1 |
| Doiron, JE; Goodchild, TT; Koul, K; LaPenna, KB; Lefer, DJ; Li, Z; Moles, K; Patel, RB; Polhemus, DJ; Shah, SJ; Sharp, TE; Wang, JS; Xia, H | 1 |
| Balkan, W; Cai, R; Dulce, RA; Hare, JM; Kanashiro-Takeuchi, RM; Kazmierczak, K; Schally, AV; Sha, W; Takeuchi, LM | 1 |
| Chen, X; Gao, L; Huang, S; Ke, J; Pan, J; Yu Chang, AC; Zhang, H; Zhang, J | 1 |
| Fan, XY; Gao, K; Guo, SZ; Li, FH; Li, S; Pu, HY; Tang, JY; Wei, XQ; Yu, X | 1 |
| Gillette, TG; Hill, JA; Jiang, N; Lavandero, S; May, HI; Schiattarella, GG; Tong, D | 1 |
| Paulus, WJ | 1 |
| Blanco-Rivero, J; Couto, GK; Fontes, MT; Paula, SM; Rossoni, LV | 1 |
| Chen, JS; Chen, JW; Huang, PH; Huang, WP; Lin, SJ; Yin, WH | 1 |
| Ackerstaff, J; Becker-Pelster, EM; Fey, P; Follmann, M; Geiss, V; Gerisch, M; Griebenow, N; Jautelat, R; Kern, A; Knorr, A; Kretschmer, A; Kroh, W; Lang, D; Li, V; Lustig, K; Mittendorf, J; Mondritzki, T; Redlich, G; Sandner, P; Schirok, H; Schlemmer, KH; Stasch, JP; Straub, A; Tinel, H; Trübel, H; Wunder, F | 1 |
| Fraidenburg, DR; Han, Y; Ren, X; Sun, S; Tang, H; Zhang, F; Zhao, M; Zhao, Z | 1 |
| Altamirano, F; French, KM; Gillette, TG; Hahn, VS; Hill, JA; Hill, TM; Huang, J; Jiang, N; Kass, DA; Kim, SY; Lavandero, S; Lee, DI; Luo, X; Mammen, PPA; May, HI; Schiattarella, GG; Sharma, K; Tong, D; Villalobos, E; Wang, ZV | 1 |
| Chibbar, R; Lane, N; Ndisang, JF | 1 |
| Hood, SG; May, CN; Ramchandra, R | 1 |
| Fernandes, AA; Padilha, AS; Silveira, EA; Siman, FD; Stefanon, I; Vassallo, DV | 1 |
| Hirai, M; Inden, Y; Murohara, T; Shimano, M; Takefuji, M; Tsuji, Y; Yamamoto, T; Yanagisawa, S; Yoshida, N | 1 |
| Csonka, C; Deten, A; Ferdinandy, P; Pipicz, M; Rebelo, M; Rohrbach, S; Schlüter, KD; Schreckenberg, R; Schulz, R; Weber, M | 1 |
| Britto, LR; Couto, GK; Mill, JG; Rossoni, LV | 1 |
| Cao, TN; Cordero-Reyes, AM; Gupte, AA; Hamilton, DJ; Li, S; Smith, JA; Torre-Amione, G; Vedula, I; Youker, KA; Zhang, A | 1 |
| Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA | 1 |
| Lionetti, V | 1 |
| Bajuszova, Z; Gazova, A; Klimas, J; Kmecova, J; Krenek, P; Kucerova, D; Kyselovic, J; Musil, P; Ochodnicky, P | 1 |
| Elgner, A; Kockskämper, J; Pieske, B; Post, H; von Lewinski, D; Zhu, D | 1 |
| Douglas, SA; Kimbrough, CL; Kubo, H; Margulies, KB; Quaile, MP | 1 |
| Fukushima, H; Ishimitsu, T; Kobayashi, N; Koguchi, W; Takeshima, H | 1 |
| di Stolfo, G; Dragoni, S; Gori, T; Lisi, M; Liuni, A; Luca, MC; Mariani, JA; Parker, JD; Uxa, A | 1 |
| Curry, PL; Gao, L; Haack, KK; Pellegrino, PR; Schiller, AM; Zucker, IH | 1 |
| Devine, A; Dixon, LJ; El-Sherbeeny, NA; Hughes, SM; Johnston, GD; Leahey, W; McGrath, LT; McVeigh, GE; Morgan, DR; Plumb, RD | 1 |
| Gaballa, M; Goldman, S; Thai, H; Wollmuth, J | 1 |
| Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H | 1 |
| Gaballa, MA; Goldman, S; Spooner, PH; Thai, HM | 1 |
| Dixon, LJ; Hanratty, CG; Hughes, SM; Johnston, GD; Leahey, WJ; McVeigh, GE; Morgan, DR; Rooney, KP | 1 |
| Pereira, RB; Sartório, CL; Stefanon, I; Vassallo, DV | 1 |
| Maehara, K; Maruyama, Y; Oikawa, Y; Saito, T; Tamagawa, K; Yaoita, H | 1 |
| Okruhlicova, L; Sotnikova, R; Tribulova, N; Weismann, P | 1 |
| Kong, YH; Li, WM; Tian, Y; Xue, JY | 1 |
| Cittadini, A; Condorelli, G; Di Gianni, A; Di Rella, F; Iaccarino, G; Monti, MG; Peschle, C; Saccà, L; Sorriento, D; Strömer, H; Trimarco, B; Tsichlis, PN | 1 |
| Liu, JL; Zucker, IH | 1 |
| Bilsborough, W; Burke, V; Erickson, M; Green, DJ; Maiorana, AJ; Minson, CT; O'Driscoll, G; Siong, JH | 1 |
| Abassi, Z; Hoffman, A; Kaballa, A; Ovcharenko, E; Rubinstein, I; Winaver, J | 1 |
| Dixon, LJ; El-Sherbeeny, N; Hamilton, PB; Hanratty, CG; Johnston, GD; Leahey, WJ; McGrath, LT; McVeigh, GE; Morgan, DR | 1 |
| Böttiger, BW; Motsch, J; Rauch, H | 1 |
| Asano, Y; Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Minamino, T; Okada, K; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H; Tsukamoto, O; Yamasaki, S; Yulin, L | 1 |
| Bellomo, M; Floyd, BC; Gupte, RS; Gupte, SA; Labinskyy, V; Levine, RJ; Lionetti, V; Ojaimi, C; Recchia, FA; Wolin, MS; Young, ME | 1 |
| Ferreira, LF; Hageman, KS; Hahn, SA; Musch, TI; Padilla, DJ; Poole, DC; Williams, J | 1 |
| Kukreja, RC | 1 |
| Ardell, JL; Johnson, WH; Pitts, VH; Townsley, MI; Zhao, Z | 1 |
| Lüscher, TF; Noll, G; Novosel, D; Tschudi, MR | 1 |
| Hirai, T; Musch, TI; Zelis, R | 1 |
| Clozel, JP; Clozel, M; Gray, GA; Teerlink, JR | 1 |
| Blaise, G; Dumont, L; Jasmin, G; Tanguay, M | 2 |
| Matsui, S; Matsumori, A; Okada, I; Sasayama, S; Sato, Y; Shioi, T; Shiota, K; Suzuki, H; Wang, WZ; Yamada, T | 1 |
| Egashira, K; Katoh, M; Saito, K; Tada, H; Tagawa, H; Takahashi, M; Takeshita, A; Tsutsui, H; Yamamoto, M; Yamamoto, S | 1 |
| Hintze, TH; Shen, W; Wolin, MS | 1 |
| Lim, SL; Man, RY; Nekooeian, AA; Pang, CC | 1 |
| Ma, R; Wang, W; Zucker, IH | 1 |
| Gaballa, MA; Goldman, S | 1 |
| Ceiler, DL; De Mey, JG; Nelissen-Vrancken, M; Smits, JF | 1 |
| Addonizio, L; Gersony, WM; Hintze, TH; Loke, KE; Mital, S; Slater, JP | 1 |
| Maehara, K; Maruyama, Y; Mitsugi, M; Niitsuma, T; Saito, T; Saitoh, S; Sato, M; Tamagawa, K | 1 |
| Gutterman, DD; Liu, Y; Loberiza, F; Miura, H; Terata, K | 1 |
| Arnold, JM; Feng, Q; Hammond, JR; Lu, X; McCormack, DG; Scott, JA; Shen, J; Stathopulos, PB | 1 |
| Abassi, Z; Brezis, M; Goldfarb, M; Heyman, SN; Rosen, S; Shina, A | 1 |
| Arai, Y; Egashira, K; Katsuda, Y; Shimokawa, H; Tada, H; Takeshita, A; Usui, M; Yamamoto, M | 1 |
| Aubert, ML; Blum, WF; Dietz, R; Höhnel, K; Langenickel, T; Nüssler, AK; Pagel, I; Philipp, S; Willenbrock, R | 1 |
2 review(s) available for ng-nitroarginine methyl ester and Heart Failure
| Article | Year |
|---|---|
Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
Topics: Angiotensin II; Animals; Baroreflex; Cardiac Output, Low; Disease Models, Animal; Excitatory Postsynaptic Potentials; Exercise; Heart Failure; Hemodynamics; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Risk Factors; Sensitivity and Specificity; Sympathetic Nervous System | 2000 |
Newer approaches to the pharmacological management of heart failure.
Topics: Calcium Signaling; Cardiotonic Agents; Cardiovascular Agents; Endothelins; Enzyme Inhibitors; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridazines; Pyridines; Simendan; Tetrazoles | 2006 |
1 trial(s) available for ng-nitroarginine methyl ester and Heart Failure
| Article | Year |
|---|---|
Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure.
Topics: Acetylcholine; Aged; Angiotensin II; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium-Dependent Relaxing Factors; Fatty Acids, Omega-3; Female; Forearm; Heart Failure; Humans; Male; NG-Nitroarginine Methyl Ester; Nitroprusside; Olive Oil; Plant Oils; Plethysmography | 2006 |
65 other study(ies) available for ng-nitroarginine methyl ester and Heart Failure
| Article | Year |
|---|---|
Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload.
Topics: Animals; Blood Pressure; Heart Failure; Homoarginine; Hypertension; Lisinopril; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Spironolactone; Ventricular Remodeling | 2022 |
Biological Activity of a 4-Hydroxy-Furanyl-Benzamide Derivative on Heart Failure.
Topics: Animals; Benzamides; Heart; Heart Failure; Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Rats | 2023 |
Phosphodiesterases type 2, 3 and 4 promote vascular tone in mesenteric arteries from rats with heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Endothelial Cells; Heart Failure; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar | 2023 |
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model.
Topics: Animals; Disease Models, Animal; Drinking Water; Heart Failure; Hydralazine; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Sodium Nitrite; Stroke Volume | 2023 |
Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Growth Hormone-Releasing Hormone; Heart Failure; Inflammation; Mice; NG-Nitroarginine Methyl Ester; Stroke Volume; Vascular Endothelial Growth Factor A; Ventricular Function, Left | 2023 |
Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α.
Topics: Animals; Cystathionine gamma-Lyase; Heart Failure; Hydrogen Sulfide; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Stroke Volume | 2023 |
[Mechanism of Jiming Powder in ameliorating heart failure with preserved ejection fraction based on metabolomics].
Topics: Animals; Biomarkers; Chromatography, Liquid; Heart Failure; Male; Metabolomics; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Powders; Stroke Volume; Tandem Mass Spectrometry; Water | 2023 |
Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
Topics: Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose Intolerance; Heart Failure; Humans; Hypertension; Male; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Obesity; Risk Factors; Sex Characteristics; Sex Factors; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling; Weight Gain | 2019 |
Unfolding Discoveries in Heart Failure.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Endoribonucleases; Heart Failure; Heart Failure, Diastolic; Humans; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrosative Stress; Stroke Volume | 2020 |
Enhanced sympathetic neurotransduction in the superior mesenteric artery in a rat model of heart failure: role of noradrenaline and ATP.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Enzyme Inhibitors; Heart Failure; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroprusside; Norepinephrine; Phentolamine; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Suramin; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 2021 |
Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Endothelial Progenitor Cells; Endothelium; Fenofibrate; Heart Failure; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A | 2021 |
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.
Topics: Administration, Intravenous; Administration, Oral; Animals; Blood Pressure; Chemistry Techniques, Synthetic; Dogs; Heart Failure; Hepatocytes; Heterocyclic Compounds, 2-Ring; Humans; Male; NG-Nitroarginine Methyl Ester; Pyrimidines; Rats, Transgenic; Rats, Wistar; Soluble Guanylyl Cyclase; Structure-Activity Relationship | 2017 |
Angiotensin-(1-7) in Paraventricular Nucleus Contributes to the Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activity in Chronic Heart Failure Rats.
Topics: Acetophenones; Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Capsaicin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic N-Oxides; Heart Failure; Hemodynamics; Kidney; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction; Spin Labels; Superoxides; Sympathetic Nervous System | 2017 |
Nitrosative stress drives heart failure with preserved ejection fraction.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Endoribonucleases; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitrosative Stress; Phenotype; Protein Serine-Threonine Kinases; Signal Transduction; Stroke Volume; X-Box Binding Protein 1 | 2019 |
Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
Topics: Adiponectin; Aldosterone; Animals; Antioxidants; Arginine; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Chemokine CCL2; Chemokine CCL3; Cyclic GMP; Dinoprost; Endothelin-1; Enzyme Induction; Extracellular Matrix Proteins; Heart Failure; Heme; Heme Oxygenase (Decyclizing); Hypertension; Interleukin-1beta; Interleukin-6; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine | 2014 |
Central exogenous nitric oxide decreases cardiac sympathetic drive and improves baroreflex control of heart rate in ovine heart failure.
Topics: Animals; Baroreflex; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Female; Heart; Heart Failure; Heart Rate; Injections, Intraventricular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitroprusside; Sheep; Sympathetic Nervous System | 2014 |
Ouabain induces nitric oxide release by a PI3K/Akt-dependent pathway in isolated aortic rings from rats with heart failure.
Topics: Animals; Aorta, Thoracic; Heart Failure; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ouabain; Phenylephrine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar | 2015 |
Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits.
Topics: Animals; Atrial Fibrillation; Blotting, Western; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Echocardiography; Electrophysiology; Endothelium; Enzyme-Linked Immunosorbent Assay; Fibrosis; Fluorescent Antibody Technique; Heart Atria; Heart Failure; Male; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphorylation; Piperidines; Rabbits; Tachycardia, Ventricular; Uracil | 2015 |
Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense.
Topics: Animals; Cells, Cultured; Enzyme Induction; Female; Heart Failure; Homeostasis; Myocardial Contraction; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Oxidation-Reduction; Oxidative Stress; Protective Factors; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Up-Regulation; Ventricular Remodeling | 2015 |
Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction.
Topics: Acetylcholine; Animals; Biological Availability; Coronary Occlusion; Coronary Vessels; Endothelium, Vascular; Heart Failure; Humans; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Vasodilation; Vasodilator Agents | 2015 |
Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; DNA, Mitochondrial; Electron Transport Complex I; Electron Transport Complex II; Enzyme Inhibitors; Gene Expression; Heart; Heart Failure; Hydrogen Peroxide; Mice; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Protein Precursors; Pyruvate Dehydrogenase Complex; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Vasoconstrictor Agents | 2016 |
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Simultaneous exposure to nitric oxide inhibition and angiotensin II overload: is it a murine model of mitochondrial dysfunction in nonischemic heart failure?
Topics: Angiotensin II; Animals; Disease Models, Animal; Heart Failure; Mice; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress | 2016 |
Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Electrocardiography; Enzyme Inhibitors; Heart Atria; Heart Failure; Heart Rate; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar | 2009 |
Reduced stretch-induced force response in failing human myocardium caused by impaired Na(+)-contraction coupling.
Topics: Adult; Blotting, Western; Enzyme Inhibitors; Heart Failure; Humans; Middle Aged; Muscle Contraction; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Reflex, Stretch; Signal Transduction; Sodium; Sodium-Calcium Exchanger | 2009 |
Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium.
Topics: Adult; Blotting, Western; Enzyme Inhibitors; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Signal Transduction; Sodium; Sodium-Hydrogen Exchangers; Urotensins | 2009 |
Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Topics: Adipokines; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Apelin Receptors; Carrier Proteins; Disease Models, Animal; Down-Regulation; Heart Failure; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Receptors, G-Protein-Coupled; Signal Transduction; Tetrazoles | 2010 |
Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: implications for the accurate assessment of endothelial function.
Topics: Adolescent; Adult; Analysis of Variance; Brachial Artery; Coronary Artery Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Regional Blood Flow; Smoking; Vasodilation | 2010 |
Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Baroreflex; Brain Stem; Chronic Disease; Consciousness; Enzyme Inhibitors; Heart; Heart Failure; Heart Rate; Male; Metoprolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Phenylephrine; Rabbits; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Sympathetic Nervous System; Vagus Nerve | 2013 |
Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure.
Topics: Aged; Blood Platelets; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Regional Blood Flow; Superoxides; Vasodilation | 2003 |
Angiotensin subtype 1 rReceptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cattle; Cells, Cultured; Enzyme Inhibitors; Heart Failure; Hemodynamics; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Tetrazoles; Up-Regulation; Vascular Resistance; Ventricular Function, Left | 2003 |
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents | 2004 |
Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarction.
Topics: Acetylcholine; Animals; Cattle; Cells, Cultured; Coronary Vessels; Diiodothyronines; Endothelium, Vascular; Heart Failure; Hemodynamics; Isoproterenol; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Vasodilator Agents; Ventricular Function, Left | 2004 |
Impaired endothelium-dependent and -independent vasodilation in elderly patients with chronic heart failure.
Topics: Acetylcholine; Aged; Aged, 80 and over; Area Under Curve; Case-Control Studies; Chronic Disease; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Failure; Humans; Male; NG-Nitroarginine Methyl Ester; Nitroprusside; Plethysmography; Regional Blood Flow; Stroke Volume; United Kingdom; Vasodilation; Vasodilator Agents | 2004 |
Differences in tail vascular bed reactivity in rats with and without heart failure following myocardial infarction.
Topics: Animals; Dose-Response Relationship, Drug; Heart Failure; Indomethacin; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Rats; Rats, Wistar; Tail; Vasoconstriction | 2005 |
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Cineangiography; Coronary Angiography; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Heart Failure; Injections, Intra-Arterial; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Propranolol; Quinazolines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vascular Resistance; Vasodilation; Yohimbine | 2005 |
Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension.
Topics: Animals; Capillaries; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Endothelial Cells; Heart Failure; Hypertension; Immunohistochemistry; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Streptozocin | 2005 |
[Effects of NG-nitro-L-arginine methyl ester on hemodynamics and beta-adrenoreceptors mRNA in rats with heart failure after beta3-adrenergic receptors agonist injection].
Topics: Adrenergic Agonists; Animals; Cyclic GMP; Heart Failure; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3; RNA, Messenger | 2005 |
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling.
Topics: Adenoviridae; Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Dobutamine; Echocardiography; Genetic Therapy; Genetic Vectors; Heart Failure; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Perfusion; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Transduction, Genetic | 2006 |
Impaired skin blood flow response to environmental heating in chronic heart failure.
Topics: Blood Flow Velocity; Blood Pressure; Body Temperature; Body Temperature Regulation; Chronic Disease; Enzyme Inhibitors; Heart Failure; Heating; Hot Temperature; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Skin; Vasodilation | 2006 |
Renal effects of human urotensin-II in rats with experimental congestive heart failure.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Indomethacin; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Probability; Rats; Rats, Wistar; Reference Values; Renal Circulation; Risk Factors; Sensitivity and Specificity; Up-Regulation; Urodynamics; Urotensins | 2006 |
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Topics: Actins; Aldosterone; Animals; Blotting, Western; Cytochrome P-450 CYP11B2; Drug Therapy, Combination; Eplerenone; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Immunohistochemistry; Male; Mineralocorticoid Receptor Antagonists; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proliferating Cell Nuclear Antigen; Protein Precursors; Random Allocation; Rats; Rats, Inbred WKY; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.
Topics: 6-Aminonicotinamide; Animals; Blood Pressure; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Enzyme Inhibitors; Glucosephosphate Dehydrogenase; Heart Failure; Humans; NADP; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Superoxides; Teratogens; Time Factors | 2006 |
Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availability.
Topics: Animals; Blood Vessels; Exercise Tolerance; Heart Failure; Male; Microcirculation; Muscle, Skeletal; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Oxygen; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2006 |
Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Carbolines; Cardiomyopathies; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Doxorubicin; Endothelium, Vascular; Enzyme Inhibitors; Erectile Dysfunction; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Imidazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents; Ventricular Remodeling | 2007 |
Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Animals; Arginine; Cardiac Pacing, Artificial; Dogs; Heart Failure; Hemodynamics; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Pulmonary Circulation; Sympatholytics | 1994 |
Activity of the L-arginine/nitric oxide pathway and endothelin-1 in experimental heart failure.
Topics: Acetylcholine; Animals; Aorta; Arginine; Body Weight; Cricetinae; Disease Models, Animal; Endothelins; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Male; Mesenteric Arteries; Mesocricetus; Muscle Relaxation; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Organ Size; Vascular Resistance | 1994 |
Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure.
Topics: Animals; Arginine; Blood Pressure; Female; Heart Failure; Heart Rate; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance | 1995 |
Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release.
Topics: Animals; Aorta, Thoracic; Arginine; Cyclic GMP; Endothelium, Vascular; Heart Failure; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Impaired coronary sensitivity to diltiazem in experimental heart failure: involvement of the cyclooxygenase but not the nitric oxide-synthase pathway.
Topics: Animals; Coronary Vessels; Cricetinae; Cyclooxygenase Inhibitors; Diltiazem; Enzyme Inhibitors; Heart Failure; Heart Rate; Hemodynamics; In Vitro Techniques; Indomethacin; Mesocricetus; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Vasodilator Agents; Ventricular Function, Left | 1996 |
Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production.
Topics: Amlodipine; Animals; Body Weight; Calcium Channel Blockers; Cardiovirus Infections; Disease Models, Animal; Encephalomyocarditis virus; Heart; Heart Failure; Male; Mice; Mice, Inbred DBA; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size | 1997 |
Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Cells, Cultured; Dogs; Electric Stimulation; Heart; Heart Failure; Isoproterenol; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Sarcomeres; Ventricular Function, Left | 1997 |
Coronary and cardiac sensitivity to the vasoselective benzothiazepine-like calcium antagonist, clentiazem, in experimental heart failure.
Topics: Animals; Body Weight; Calcium Channel Blockers; Chronic Disease; Coronary Vessels; Cricetinae; Cyclooxygenase Inhibitors; Diltiazem; Enzyme Inhibitors; Heart; Heart Failure; In Vitro Techniques; Indomethacin; Mesocricetus; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase | 1997 |
Defective endogenous nitric oxide-mediated modulation of cellular respiration in canine skeletal muscle after the development of heart failure.
Topics: 2,4-Dinitrophenol; Animals; Bradykinin; Carbachol; Cardiac Pacing, Artificial; Cell Respiration; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Metabolic Diseases; Mitochondria, Muscle; Muscarinic Agonists; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen Consumption; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Tachycardia; Uncoupling Agents | 1997 |
Chronic 17beta-estradiol augments relaxant role of basal nitric oxide in blood vessels from rats with heart failure.
Topics: Acetylcholine; Anesthesia; Animals; Aorta, Thoracic; Blood Vessels; Drug Synergism; Estradiol; Female; Heart Failure; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Portal Vein; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Time Factors | 1998 |
Reduced NO enhances the central gain of cardiac sympathetic afferent reflex in dogs with heart failure.
Topics: Afferent Pathways; Animals; Dogs; Enzyme Inhibitors; Female; Heart Conduction System; Heart Failure; Hemodynamics; Injections, Intraventricular; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Reflex; Sympathetic Nervous System; Vasodilator Agents | 1999 |
Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo.
Topics: Acetylcholine; Animals; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; Heart Failure; Hemodynamics; Hindlimb; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Phenylephrine; Rats; Rats, Sprague-Dawley; Transfection; Transgenes; Vasoconstrictor Agents; Vasodilation | 1999 |
Role of basal nitric oxide synthesis in vasoconstrictor hyporeactivity in the perfused rat hindlimb after myocardial infarction: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelium, Vascular; Heart Failure; Hindlimb; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Rats; Rats, Wistar; Vasoconstriction | 1999 |
Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Calcium Channel Blockers; Child; Coumarins; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Isocoumarins; Male; Middle Aged; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Penicillamine; Ramipril; Serine Proteinase Inhibitors | 1999 |
Augmented basal nitric oxide production contributes to maintenance of coronary blood flow in dogs with pacing-induced heart failure.
Topics: Animals; Cardiac Pacing, Artificial; Coronary Angiography; Coronary Circulation; Diastole; Dogs; Female; Heart Failure; Hemodynamics; Indomethacin; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vascular Resistance | 1999 |
Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels.
Topics: Adenine; Adrenomedullin; Aged; Arterioles; Calcitonin Gene-Related Peptide; Coronary Circulation; Coronary Disease; Coronary Vessels; Enzyme Inhibitors; Female; Heart Failure; Humans; Hypertension; In Vitro Techniques; Male; Microcirculation; Middle Aged; Miotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Peptide Fragments; Potassium Channels; Vasodilation; Vasodilator Agents | 2000 |
Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure.
Topics: Animals; Aorta; Arginine; Blood Pressure; Disease Models, Animal; DNA Primers; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Failure; Heart Rate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Tritium; Tumor Necrosis Factor-alpha; Ventricular Pressure | 2001 |
Compensated heart failure predisposes to outer medullary tubular injury: studies in rats.
Topics: Acute Kidney Injury; Animals; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Enzyme Inhibitors; Heart Failure; Hypoxia; Indomethacin; Kidney Medulla; Kidney Tubular Necrosis, Acute; Loop of Henle; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstriction; Vasodilation | 2001 |
Role of nitric oxide in regulation of coronary blood flow in response to increased metabolic demand in dogs with pacing-induced heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Energy Metabolism; Enzyme Inhibitors; Heart Failure; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Pacemaker, Artificial; Vasodilation | 2001 |
Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cyclic GMP; Enzyme Inhibitors; Growth Hormone; Heart; Heart Failure; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar; Recombinant Proteins; RNA, Messenger; Ventricular Dysfunction, Left | 2002 |